Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ASE group companies market commercial-stage pharmaceuticals, including unique fermentation-based APIs (notably amphotericin B for invasive fungal infections), oncology and infertility products, and proprietary rapid PCR diagnostics. Key group assets include India's only dedicated amphotericin B plant and one of the first Indian molecular diagnostic PCR test licenses for COVID-19.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ambalal Sarabhai Enterprises.